Reduced Serological Response to COVID-19 Vaccines in Patients with IBD is Further Diminished by TNF Inhibitor Therapy; Early Results of the VARIATION study [VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON]

被引:12
作者
Doherty, Jayne [1 ,2 ,10 ]
Morain, Neil O. [1 ,2 ]
Stack, Roisin [1 ,2 ]
Girod, Parker [1 ]
Tosetto, Miriam [2 ]
Inzitiari, Rosanna [2 ]
Sheridan, Juliette [1 ,2 ,3 ]
Cullen, Garret [1 ,2 ,3 ,10 ]
Mc Dermott, Edel [1 ,3 ]
Buckley, Maire [1 ,3 ,4 ]
Horgan, Gareth [1 ,3 ,5 ]
Mulcahy, Hugh [1 ,2 ,3 ]
Ryan, Elizabeth J. [6 ]
Daghfal, David [7 ]
Doran, Peter [2 ]
Morain, Colm O. [8 ,9 ,10 ]
Doherty, Glen A. [1 ,2 ,3 ,10 ]
机构
[1] St Vincents Univ Hosp, Ctr Colorectal Dis, Elm Pk, Dublin 4, Ireland
[2] Univ Coll Dublin, Sch Med, Dept Gastroenterol, Dublin, Ireland
[3] St Vincents Private Hosp, Dept Gastroenterol, Dublin, Ireland
[4] St Michaels Hosp, Dept Gastroenterol, Dun Laoghaire, Co Dublin, Ireland
[5] St Columcilles Hosp, Dept Gastroenterol, Loughlinstown, Co Dublin, Ireland
[6] Univ Limerick, Hlth Res Inst, Dept Biol Sci, Limerick, Ireland
[7] Abbott Labs, Abbott Diagnost, Diagnost Div, Lake Forest, IL 60045 USA
[8] Beacon Hosp, Dept Gastroenterol, Sandyford, Co Dublin, Ireland
[9] Trinity Coll Dublin, Dublin, Ireland
[10] INITIat IBD Res Network, Res Div, Dublin, Ireland
关键词
Inflammatory bowel disease; COVID-19; vaccination; anti-tumour necrosis factor antagonists; INFLAMMATORY-BOWEL-DISEASE; VACCINATION; IMMUNE; MATURATION; DEFICIENT; ALPHA;
D O I
10.1093/ecco-jcc/jjac029
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims Evidence suggests patients with inflammatory bowel disease [IBD] receiving TNF antagonists have attenuated response to vaccination against COVID-19. We sought to determine the impact of IBD and of various medications for treatment of IBD on antibody responses to vaccination against COVID-19. Methods Patients with IBD [n = 270] and healthy controls [HC, n = 116] were recruited prospectively, and quantitative antibody responses were assessed following COVID-19 vaccination. The impact of IBD and of medications for treatment of IBD on vaccine response rates was investigated. Results Of HC, 100% seroconverted following complete vaccination with two vaccine doses; 2% of patients with IBD failed to seroconvert. Median anti-spike protein [SP] immunoglobulin [Ig]G levels following complete vaccination in our IBD cohort was significantly lower than among HC [2613 AU/mL versus 6871 AU/mL, p <= 0.001]. A diagnosis of IBD was independently associated with lower anti-SP IgG levels [beta coefficient -0.2, p = 0.001]. Use of mRNA vaccines was independently associated with higher anti-SP IgG levels [beta coefficient 0.25, p <= 0.001]. Patients with IBD receiving TNF inhibitors had significantly lower anti-SP IgG levels [2445 AU/mL] than IBD patients not receiving TNF inhibitors [3868 AU/mL, p <= 0.001]. Patients with IBD not receiving TNF inhibitors still showed attenuated responses compared with HC [3868 AU/mL versus 8747 AU/mL, p = 0.001]. Conclusions Patients with IBD have attenuated serological responses to SARS-CoV-2 vaccination. Use of anti-TNF therapy negatively affects anti-SP IgG levels further. Patients who do not seroconvert following vaccination are a particularly vulnerable cohort. Impaired responses to vaccination in our study highlight the importance of booster vaccination programmes for patients with IBD.
引用
收藏
页码:1354 / 1362
页数:9
相关论文
共 45 条
[1]  
Abbott Alinity, 2021, SARS COV 2 IGG 2 QUA
[2]   Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease [J].
Alexander, James L. ;
Selinger, Christian P. ;
Powell, Nick .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12) :987-988
[3]  
[Anonymous], 2021, ECCO TASKFORCE 7 INT
[4]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[5]   Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis [J].
Baumgart, DC ;
Sturm, A ;
Wiedenmann, B ;
Dignass, AU .
GUT, 2005, 54 (12) :1822-1823
[6]   Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients [J].
Benotmane, Ilies ;
Gautier-Vargas, Gabriela ;
Cognard, Noelle ;
Olagne, Jerome ;
Heibel, Francoise ;
Braun-Parvez, Laura ;
Martzloff, Jonas ;
Perrin, Peggy ;
Moulin, Bruno ;
Fafi-Kremer, Samira ;
Caillard, Sophie .
KIDNEY INTERNATIONAL, 2021, 99 (06) :1487-1489
[7]  
Centres for Disease Control and Prevention, 2019, COVID 19 YOUR HLTH
[8]   Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease [J].
Cullen, Garret ;
Bader, Caroline ;
Korzenik, Joshua R. ;
Sands, Bruce E. .
GUT, 2012, 61 (03) :385-391
[9]   Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα [J].
Edelman-Klapper, Hadar ;
Zittan, Eran ;
Shitrit, Ariella Bar-Gil ;
Rabinowitz, Keren Masha ;
Goren, Idan ;
Avni-Biron, Irit ;
Ollech, Jacob E. ;
Lichtenstein, Lev ;
Banai-Eran, Hagar ;
Yanai, Henit ;
Snir, Yifat ;
Pauker, Maor H. ;
Friedenberg, Adi ;
Levy-Barda, Adva ;
Segal, Arie ;
Broitman, Yelena ;
Maoz, Eran ;
Ovadia, Baruch ;
Golan, Maya Aharoni ;
Shachar, Eyal ;
Ben-Horin, Shomron ;
Perets, Tsachi-Tsadok ;
Ben Zvi, Haim ;
Eliakim, Rami ;
Barkan, Revital ;
Goren, Sophy ;
Navon, Michal ;
Krugliak, Noy ;
Werbner, Michal ;
Alter, Joel ;
Dessau, Moshe ;
Gal-Tanamy, Meital ;
Freund, Natalia T. ;
Cohen, Dani ;
Dotan, Iris .
GASTROENTEROLOGY, 2022, 162 (02) :454-467
[10]   Innate and adaptive immunity in inflammatory bowel disease [J].
Geremia, Alessandra ;
Biancheri, Paolo ;
Allan, Philip ;
Corazza, Gino R. ;
Di Sabatino, Antonio .
AUTOIMMUNITY REVIEWS, 2014, 13 (01) :3-10